The worldwide prevalence of type 2 diabetes mellitus (T2DM) and its associated complications resulting from insufficiency of insulin secretion and resistance have increased noticeably and tremendously contribute to the global burden of disability and mortality [1]. The gene discussed is INS; the disease is type 2 diabetes mellitus.